New
HealthMore in Health→
Aldosterone Drug Shows Lasting Blood-Pressure Benefit
Key Takeaways
- The 14-person study examined a six- to 12-month course of aldosterone synthase inhibition.
- Researchers reported sustained improvement for up to two years after treatment stopped.
- The approach targets primary aldosteronism, a hormonal cause estimated to account for 5% to 10% of hypertension cases.
DE
DT Editorial Team··via medicalxpress.com